Label: TRANEXAMIC ACID injection, solution

  • NDC Code(s): 14593-318-01
  • Packager: Emcure Pharmaceuticals Limited
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated October 28, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • INDICATIONS AND USAGE
    Tranexamic acid injection, USP is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and ...
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
    NDC 14593-318-01 - Tranexamic Acid Injection, USP - 1000 mg/10 mL - (100 mg/mL) Intravenous Use Only - Rx only - 10 mL Single-Dose Vial
  • INGREDIENTS AND APPEARANCE
    Product Information
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!